MediciNova Inc expected to post a loss of 9 cents a share - Earnings Preview

Medicinova

04/08/2021 03:51

* MediciNova Inc  MNOV.OQ   MNOV.O  is expected to show a no
change in quarterly revenue when it reports results on August 4
(estimated). 
​* Refinitiv's mean analyst estimate for MediciNova Inc is for a
loss of 9 cents per share. For the same quarter last year, the
company reported a loss of 10 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for MediciNova Inc
is $15​, about 75.3% above​ its last closing price of $3.70. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.08       -0.08      0.00      Beat    100
 Dec. 31 2020              -0.09      -0.06     Beat    36.7
 Sep. 30 2020  -0.11       -0.12      -0.08     Beat    33.3​
 Jun. 30 2020  -0.15       -0.10      -0.10     Met     0
 Mar.          -0.08​      -0.08      -0.06     Beat    25​
 31​ 2020​                                              
 Dec. 31 2019  -0.08       -0.08      -0.05     Beat    37.5​
 Sep. 30 2019              -0.15      -0.05     Beat    66.7
 Jun. 30 2019  -0.14       -0.12      -0.09     Beat    25
 This summary was machine generated August 4 at 02:50 GMT.  All
figures in US dollars unless otherwise stated